|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.390 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 784,694 | -10.478% | 1,813,807 | 1,669,817 | 1,736,972 | 1,317,711 |
| Cost of Sales | (128,434) | 31.146% | (195,921) | (171,154) | (174,943) | (128,382) |
| Gross Profit | 656,260 | -15.713% | 1,617,886 | 1,498,663 | 1,562,029 | 1,189,329 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (162) | (2,911) | (1,641) | (194) | |
| Profit / (Loss) before Taxation | 147,968 | -27.315% | 414,662 | 375,500 | 346,014 | 260,343 | |
| Taxation | (37,248) | -7.279% | (96,571) | (68,278) | (70,755) | (34,931) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 110,720 | -32.240% | 318,091 | 307,222 | 275,260 | 225,411 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | (2,966) | 13.163% | (4,014) | (5,359) | (1,131) | 2,594 |
| Depreciation & Amortisation | 35,662 | 25.319% | 62,592 | 55,873 | 59,876 | 41,913 |
| Directors' Emoluments | -- | -- | 8,439 | 8,277 | 8,331 | 8,594 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 19.530 | -32.235% | 56.100 | 54.140 | 48.270 | 39.270 |
| DPS (cts) | 5.000 | -- | 14.000 | 12.000 | 9.000 | 6.500 |
| Dividend Payout Ratio (%) | 25.602% | -- | 24.955% | 22.165% | 18.645% | 16.552% |
| Cash flow per share ($) | -- | -- | 0.540 | 0.649 | 0.595 | 0.667 |
| NBV per share ($) | 4.504 | -- | 4.256 | 3.745 | 3.389 | 3.029 |
| Remarks: | Real time quote last updated: 07/08/2026 08:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 110,720 |
| %Change | -32.240% |
| EPS / (LPS) | HKD 0.195 |
| NBV Per Share ($) | HKD 4.504 |